Evidence map›Paper›PMID 19037746›Full record

ArticleThe international journal of cardiovascular imaging2009

Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease.

Theodoros D Karamitsos, Jayanth R Arnold, Tammy J Pegg, Adrian S H Cheng, William J van Gaal, Jane M Francis, Adrian P Banning, Stefan Neubauer, Joseph B Selvanayagam

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in The international journal of cardiovascular imaging, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03661827 (Diagnostic Accuracy in Left Ventricular Systolic Dysfunction for Identifying Coronary Artery Disease With Dobutamine Versus Adenosine Non-invasive Stress Cardiac Magnetic Resonance Evaluation), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03661827 nacompletednot on this mapstarted 2019, after this paper: background citation

Diagnostic Accuracy in Left Ventricular Systolic Dysfunction for Identifying Coronary Artery Disease With Dobutamine Versus Adenosine Non-invasive Stress Cardiac Magnetic Resonance Evaluation

TypeinterventionalSponsorUniversity of LeicesterRan2019 to 2023Enrolled69ConditionsHeart Failure, Coronary Artery Disease, Cardiac MRIArmsStress Cardiac MRI
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The reproducibility of breathing maneuvers as a vasoactive stimulus in the heart: an oxygenation-sensitive resonance imaging study.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2023
    Article
  5. Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR.The international journal of cardiovascular imaging · 2023
    Article
  6. Review
  7. Article
  8. Influence of the arterial input sampling location on the diagnostic accuracy of cardiovascular magnetic resonance stress myocardial perfusion quantification.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2021
    Article
  9. Review
  10. Article
  11. Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2017
    Article
  12. Article
  13. Adenosine triphosphate stressExperimental and therapeutic medicine · 2016
    Article
  14. Review
  15. Safety and tolerability of regadenoson CMR.European heart journal. Cardiovascular Imaging · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Cardiovascular magnetic resonance in heart failure.Current cardiology reports · 2011
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Theodoros D KaramitsosCentre for Clinical Magnetic Resonance Research, Department of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. theo.karamitsos@cardiov.ox.ac.uk
Jayanth R Arnold
Tammy J Pegg
Adrian S H Cheng
William J van Gaal
Jane M Francis
Adrian P Banning
Stefan Neubauer
Joseph B Selvanayagam
University of Oxford · GBJohn Radcliffe Hospital · GB

Funding

British Heart FoundationMedical Research Council
6 · The paper itself

Abstract

We sought to assess the tolerance and safety of adenosine-stress cardiovascular magnetic resonance (CMR) perfusion imaging in patients with coronary artery disease (CAD). We retrospectively examined all adenosine CMR perfusion scans performed in our centre in patients with known or suspected (CAD) and normal volunteers at either 1.5 or 3 T. All subjects were initially screened for contraindications to adenosine. The dose of adenosine infused was 140 microg/kg/min. Significant CAD was defined angiographically as the presence of at least one stenosis of >50% diameter. Data were collected from 351 consecutive subjects (mean age 62 +/- 11 years, range 25-85 years-245 men). Of the 351 subjects, 305 had a coronary angiogram, the remaining 46 subjects were normal volunteers studied for research protocols. In total, 233 subjects (76%) were found to have significant CAD of whom 128 had multi-vessel disease. There were no deaths, myocardial infarctions, or episodes of bronchospasm during the CMR study. Transient 2nd (Mobitz II) or 3rd-degree atrioventricular (AV) block occurred in 27 patients (8%). There were no sustained episodes of advanced AV block. Transient chest pain was the most common side effect (199 subjects-57%). The use of intravenous adenosine in CMR perfusion imaging is safe and well-tolerated, even in patients with severe CAD. Where a careful screening policy for contraindications to adenosine is followed, serious adverse events in the CMR scanner are relatively rare and symptoms resolve following termination of the infusion, without the need for aminophylline.

Indexed as

AdenosineExercise TestVasodilator AgentsAdultAgedAged, 80 and overAnalysis of VarianceChi-Square DistributionContrast MediaCoronary AngiographyCoronary Artery DiseaseGadolinium DTPAHumansInfusions, IntravenousMagnetic Resonance AngiographyMiddle AgedAdenosineContrast MediagadodiamideGadolinium DTPAVasodilator Agents

Identifiers

PMID19037746
OpenAlexW2080825743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.